HDAC9 and AL amyloidosis: Although not specific for SIRT1, HDAC inhibitors were found to down-regulate GLUT1 expression and to inhibit hexokinase 1 enzymatic activity in multiple myeloma cells [35], underscoring that acetylation plays a key role in regulation of glycolytic metabolism.